← Open Payments lookup

PAUL BOULWARE: Open Payments

NPI 1609912146 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,927 in 109 payments from 20 companies in 2025. Trend: 2023 $1,939 · 2024 $2,086 · 2025 $1,927

Food & beverage: $1,927
CompanyPaymentsAmount
Alkermes, Inc.10$287
ABBVIE INC.31$267
Braeburn Inc.14$210
Tris Pharma Inc9$153
Neurocrine BioSciences, Inc.7$144
Indivior Inc.5$141
Otsuka America Pharmaceutical, Inc.5$102
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$94
Janssen Pharmaceuticals, Inc4$94
Axsome Therapeutics, Inc.3$86

Products named: VRAYLAR, LYBALVI, BRIXADI, Dyanavel XR, INGREZZA, SUBLOCADE, REXULTI, CAPLYTA.

Industry payments across AZ — which companies pay providers there.